We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+28.42%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$257M
AUM Growth
–
Cap. Flow
+$237M
Cap. Flow %
92.26%
Top 10 Hldgs %
42.13%
Holding
50
New
50
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$14.8M
2
A icon
Agilent Technologies
A
+$13.4M
3
MDT icon
Medtronic
MDT
+$11.5M
4
DXCM icon
DexCom
DXCM
+$11.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$10.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 92.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGEN
26
DELISTED
Seagen Inc. Common Stock
SGEN
$3.43M 1.33%
+30,000
New +$3.18M
ARNA
27
DELISTED
Arena Pharmaceuticals Inc
ARNA
$3.18M 1.24%
+70,000
New +$3.31M
BLUE
28
DELISTED
bluebird bio
BLUE
$3.07M 1.2%
+2,702
New +$2.94M
BHC icon
29
Bausch Health
BHC
$2.4B
$2.99M 1.17%
+100,000
New +$2.6M
ZYME icon
30
Zymeworks
ZYME
$1.68B
$2.96M 1.15%
+65,000
New +$2.36M
THC icon
31
Tenet Healthcare
THC
$21B
$2.85M 1.11%
+75,000
New +$2.25M
VTRS icon
32
Viatris
VTRS
$18.8B
$2.61M 1.02%
+130,000
New +$2.42M
NVO
33
Novo Nordisk
NVO
$208B
$2.31M 0.9%
+80,000
New +$2.22M
INCY icon
34
Incyte
INCY
$24.7B
$2.18M 0.85%
+25,000
New +$2.14M
GWPH
35
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.09M 0.81%
+20,000
New +$2.24M
CI icon
36
Cigna
CI
$73.6B
$2.04M 0.8%
+10,000
New +$1.83M
CCXI
37
DELISTED
ChemoCentryx, Inc.
CCXI
$1.98M 0.77%
+50,000
New +$878K
MRTX
38
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.93M 0.75%
+15,000
New +$1.45M
TXG icon
39
10x Genomics
TXG
$7.43B
$1.91M 0.74%
+25,000
New +$1.5M
AIMT
40
DELISTED
Aimmune Therapeutics
AIMT
$1.67M 0.65%
+50,000
New +$1.4M
BMY.RT
41
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.66M 0.64%
+550,000
New +$1.43M
NKTR icon
42
Nektar Therapeutics
NKTR
$2.52B
$1.62M 0.63%
+5,000
New +$1.45M
NBIX icon
43
Neurocrine Biosciences
NBIX
$16.7B
$1.61M 0.63%
+15,000
New +$1.57M
BPMC
44
DELISTED
Blueprint Medicines
BPMC
$1.6M 0.62%
+20,000
New +$1.5M
HOLX
45
DELISTED
Hologic
HOLX
$1.57M 0.61%
+30,000
New +$1.49M
IRTC icon
46
iRhythm Holdings
IRTC
$4.08B
$1.36M 0.53%
+20,000
New +$1.36M
NERV icon
47
Minerva Neurosciences
NERV
$208M
$1.28M 0.5%
+22,500
New +$992K
APLS
48
DELISTED
Apellis Pharmaceuticals
APLS
$1.07M 0.42%
+35,000
New +$969K
GOSS icon
49
Gossamer Bio
GOSS
$87.5M
$938K 0.37%
+60,000
New +$1.21M
DTIL icon
50
Precision BioSciences
DTIL
$204M
$695K 0.27%
+1,667
New +$524K
1
2

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Integral Health Asset Management, which disclosed 50 positions worth $257M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Sage Therapeutics: 120,000 shares worth $8.66M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets.

  • Integral Health Asset Management's largest Q4 2019 buy was Sage Therapeutics: 120,000 shares worth $8.66M.
  • Integral Health Asset Management's ten largest holdings make up 42% of its $257M portfolio in Q4 2019.
  • Integral Health Asset Management disclosed 50 positions in Q4 2019, its first 13F filing on record.

Based on Integral Health Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.